Reduced Costs and Continued Cures Act

H.R. 5260 · 117th Congress · Sep 14, 2021 · Lineage

A BILL

To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients’ out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes.

Section 1 Short title; table of contents

(a)

Short title— This Act may be cited as the “Reduced Costs and Continued Cures Act”.

(b)

Table of contents— The table of contents of this Act is as follows:

Lineage

Sep 14, 2021viewing Introduced in House Mr. Peters (for himself, Mr. Schrader, Miss Rice of New York, Mrs. Murphy of Florida, and Mr. Correa) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

Reduced Costs and Continued Cures Act

Section 1 Short title; table of contents

Cite this provision

Incoming references